Viewing Study NCT04481204


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-06-30 @ 2:22 AM
Study NCT ID: NCT04481204
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-09
First Post: 2020-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Borderline Resectable Pancreatic Adenocarcinoma View
None Locally Advanced Pancreatic Ductal Adenocarcinoma View
None Resectable Pancreatic Ductal Adenocarcinoma View
Keywords: